The cut-offs for anticoagulation suggested by experts in patients with hemophilia might also be applicable for the vWF levels (Table 6); however, as in other bleeding disorders, a case by case decision, balancing the risk of bleeding with the risk of thrombosis or stroke, has to be made for each individual patient with vWD. This evidence concerns the gene VWF and hemophilia.